Sep 3, 2025 08:02AM AEMD receives patents for Hemopurifier device treating Long COVID symptoms

Aug 13, 2025 06:32PM Aethlon Medical (AEMD) Misses Q2 EPS by 85c

Jul 15, 2025 08:01AM Aethlon Medical gets safety board approval to advance clinical trial

Jan 29, 2025 08:04AM Aethlon Medical (AEMD) Treats First Patient in Australian Hemopurifier Cancer Trial

Dec 20, 2024 08:02AM Aethlon Medical (AEMD) Provides Update on the Ability of Its Hemopurifier to Capture H5N1 Bird Flu

Nov 14, 2024 08:00AM Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 14, 2024 07:40AM Maxim Group Reiterates Hold Rating on Aethlon Medical (AEMD)

Nov 12, 2024 08:00AM Innovative Medical Technology Advances with First Patient Enrollments

Sep 19, 2024 10:00AM Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024 08:01AM Aethlon Medical (AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India

Sep 17, 2024 07:30AM Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024 08:14AM Aethlon Medical (AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial

Aug 27, 2024 08:12AM Aethlon Medical (AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenate

Aug 12, 2024 09:01AM The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024 08:03AM Aethlon Medical (AEMD) Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial

Jun 25, 2024 06:42AM Aethlon Medical (AEMD) PT Lowered to $7 at H.C. Wainwright

Jun 20, 2024 07:00AM What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024 08:01AM Aethlon Medical (AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial